BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients-Reference-Cited by-同舟云学术

BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients

Published:2013-07-23 Issue:10 Volume:88 Page:848-852
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Damiani Daniela¹,Tiribelli Mario¹,Franzoni Alessandra²,Michelutti Angela¹,Fabbro Dora²,Cavallin Margherita¹,Toffoletti Eleonora¹,Simeone Erica¹,Fanin Renato¹,Damante Giuseppe²

Affiliation:

1. Division of Hematology and Bone Marrow Transplantation; Azienda Ospedaliero-Universitaria Udine; Udine Italy

2. Institute of Genetics; Azienda Ospedaliero-Universitaria Udine; Udine Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23516/fullpdf

Reference28 articles.

1. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: Are we ready for a prognostically prioritized molecular classification?;Mrozek;Blood,2007

2. Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood,2010

3. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study;Slovak;Blood,2000

4. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications;Baldus;J Clin Oncol,2006

5. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: A Cancer and Leukemia Group B (CALGB) study;Langer;Blood,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MECOM and BAALC gene expression profiles in Egyptian patients with acute myeloid leukemia by next generation sequencing;Alexandria Journal of Medicine;2024-09-11

2. The Role of BAALC Gene in the Transformation of Myeloid Progenitor Cells to Acute Myeloid Leukemia;Leukemia - From Biology to Clinic;2023-03-01

3. BAALC gene expression tells a serious patient outcome tale in NPM1-wild type/FLT3-ITD negative cytogenetically normal-acute myeloid leukemia in adults;Blood Cells, Molecules, and Diseases;2022-07

4. Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia;Blood;2022-01-20

5. Optimal time-points for detecting expression levels of BAALC, EVI1, and WT1 genes in patients with acute myeloid leukemia: a meta-analysis;Hematology;2021-01-01